[1] 宋元博,宋策,于丽.纳米药物载体在临床医学中的应用[J].临床医药文献电子杂志,2018,5(70):95-96.
[2] SILVA TH, ALVES A, FERREIRA BM, et al. Materials of marine origin: a review onpolymers and ceramics of biomedical interest. Int Mater Rev. 2012;57:276-306.
[3] SAYARI N, SILA A, ABDELMALEK BE, et al. Chitin and chitosan from the Norway lobster by products: antimicrobial and anti-proliferative activities, Int J Biol Macromol. 2016;87:163-171.
[4] DASH M, CHIELLINI F, OTTENBRITE RM, et al. Chitosan-a versatile semisynthetic polymer in biomedical applications. Prog Polym Sci. 2011;36:981-1014.
[5] YOUNES I, RINAUDO M, Chitin and chitosan preparation from marine sources. Structure, properties and applications. Mar Drugs. 2015;13(3):1133-1174.
[6] PARK JK, CHUNG MJ, CHOI HN, et al. Effects of the molecular weight and the degree of deacetylation of chitosan oligosaccharides on antitumor activity. Int J Mol Sci. 2011;12:266-277
[7] MARÍA L, DEL PRADO-AUDELO, ISAAC H, et al. Chitosan-decorated nanoparticles for drug delivery. J Drug Deliv Sci Tech. 2020:101896.
[8] NAGPAL K, SINGH SK, MISHRA DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo). 2010;58(11):1423-1430.
[9] DÜNNHAUPT S, BARTHELMES J, RAHMAT D, et al. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharm. 2012;9:1331-1341.
[10] PATRULEA V, OSTAFE V, BORCHARD G, et al. Chitosan as a starting material for wound healing applications. Eur J Pharm Biopharm. 2015; 97;417-426.
[11] RIBEIRO CV, VIEIRA RS, MELO IM, et al. Versatility of chitosan-based biomaterials and their use as scaffolds for tissue regeneration. ScientificWorldJournal. 2017;2017:8639898.
[12] NATARAJ D, SAKKARA S, MEGHWAL M, et al. Crosslinked chitosan films with controllable properties for commercial applications. Int J Biol Macromol. 2018;120:1256-1264.
[13] GUERRERO P, MUXIKA A, ZARANDONA I, et al. Crosslinking of chitosan films processed by compression molding. Carbohydr Polym. 2019;206:820-826.
[14] HUANG Y, LAPITSKY Y. On the kinetics of chitosan/tripolyphosphate micro- and nanogel aggregation and their effects on particle polydispersity. J Colloid Interface Sci. 2017;486:27-37.
[15] SACCO P, BORGOGNA M, TRAVAN A, et al. Polysaccharide-based networks from homogeneous chitosan-tripolyphosphate hydrogels: synthesis and characterization. Biomacromolecules. 2014;15(9): 3396-3405.
[16] XIE H, CHEN X, SHEN X, et al. Preparation of chitosan-collagen-alginate composite dressing and its promoting effects on wound healing. Int J Biol Macromol. 2018;107:93-104.
[17] CHEN X, FAN M, TAN H, et al. Magnetic and self-healing chitosan-alginate hydrogel encapsulated gelatin microspheres via covalent cross-linking for drug delivery. Mater Sci Eng C Mater Biol Appl. 2019; 101:619-629.
[18] YU X, WEN T, CAO P, et al. Alginate-chitosan coated layered double hydroxide nanocomposites for enhanced oral vaccine delivery. J Colloid Interface Sci. 2019;556:258-265.
[19] 赵宇,曹琬晴,刘阳.聚合物纳米药物载体的研究进展[J].高等学校化学学报,2020,41(5):909-923.
[20] WANG Y, KHAN A, LIU Y, et al. Chitosan oligosaccharide-based dual pH responsive nano-micelles for targeted delivery of hydrophobic drugs. Carbohydr Polym. 2019;223:115061.
[21] LIU X, HE Z, CHEN Y, et al. Dual drug delivery system of photothermal-sensitive carboxymethyl chitosan nanosphere for photothermal-chemotherapy. Int J Biol Macromol. 2020;163:156-166.
[22] HORO H, DAS S, MANDAL B, KUNDU LM, et al. Development of a photoresponsive chitosan conjugated prodrug nano-carrier for controlled delivery of antitumor drug 5-fluorouracil. Int J Biol Macromol. 2019;121:1070-1076.
[23] XIAO Y, GONG T, JIANG Y, et al. Fabrication and characterization of a glucose-sensitive antibacterial chitosan-polyethylene oxide hydrogel. Polymer. 2016;82:1-10.
[24] DESAI KG. Chitosan nanoparticles prepared by ionotropic gelation: an overview of recent advances. Crit Rev Ther Drug Carrier Syst. 2016; 33(2):107-158.
[25] CALVO P, REMUNAN-LOPEZ C, VILA-JATO JL, et al. Novel hydro-philic chitosan/polyethylene oxide nanoparticles as proteins carriers. J App Polym Sci. 1997;1(63):125-132.
[26] 魏谭军,董德刚,裘梁,等.离子交联法制备壳聚糖纳米颗粒[J].安徽农业科学,2012,40(5):337-338,341.
[27] SYDOW S, DE CASSAN D, HÄNSCH R, et al. Layer-by-layer deposition of chitosan nanoparticles as drug-release coatings for PCL nanofibers. Biomater Sci. 2018;7(1):233-246.
[28] OHYA Y, SHIRATANI M, KOBAYASHI H, et al. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-flu-orouracil coated with polysaccharides and their cell specific cyto-toxicity. Pure Appl Chem. 1994;31(1):629-642.
[29] XU J, MA L, LIU Y, et al. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions. Int J Biol Macromol. 2012;50(2):438-443.
[30] TAREK A, BADER A. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther. 2016;10:483-507.
[31] ESTEVINHO BN, ROCHA F, SANTOS L, et al. Microencapsulation with chitosan by spray drying for industry applications – A review. Trends Food Sci Tech. 2013;31(2):138-155.
[32] VISHALI DA, MONISHA J, SUNDARI SSK, et al. Spray freeze drying: Emerging applications in drug delivery. J Control Release. 2019;300: 93-101.
[33] SHARMA S, MUKKUR TK, BENSON HA, et al. Enhanced immune response against pertussis toxoid by IgA-loaded chitosan–dextran sulfate nanoparticles. J Pharm Sci. 2012;101:233-244.
[34] AKASH MSH, REHMAN K, CHEN S. Polymeric-based particulate systems for delivery of therapeutic proteins. Pharm Dev Technol. 2016;21: 367-378.
[35] IMPERIALE JC, SCHLACHET I, LEWICKI M, et al. Oral pharmacokinetics of a chitosan-based nano-drug delivery system of interferon alpha. Polymers (Basel). 2019;11(11):1862.
[36] ZHANG Y, ZHU W, ZHANG H, et al. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug. Docetaxel Int J Pharm. 2017;532(1):384-392.
[37] MAITY S, MUKHOPADHYAY P, KUNDU PP, et al. Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-an in vitro and in vivo approach. Carbohydr Polym. 2017;170:124-132.
[38] MU Y, FU Y, LI J, et al. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug. Carbohydr Polym. 2019;203:10-18.
[39] ZHOU X, HAO Y, YUAN L, et al. Nano-formulations for transdermal drug delivery: A review. Chinese Chem Lett. 2018;12:1713-1724.
[40] RADWAN-PRAGOWSKA J, JANUS U, PITKOWSKI M, et al. ZnO nanorods functionalized with chitosan hydrogels crosslinked with azelaic acid for transdermal drug delivery. Colloids Surf B Biointerfaces. 2020;194: 111170.
[41] ABNOOS M, MOHSENI M, MOUSAVI SAJ, et al. Chitosan-alginate nano-carrier for transdermal delivery of pirfenidone in idiopathic pulmonary fibrosis. Int J Bio Macromol. 2018:S0141813018311619.
[42] ISLAM MA, PARK TE, REESOR E, et al. Mucoadhesive chitosan derivatives as novel drug carriers. Curr Pharm Des. 2015;21(29): 4285-4309.
[43] KUMAR A, VIMAL A, KUMAR A. Why chitosan? From properties to perspective of mucosal drug delivery. Int J Biol Macromol. 2016;91: 615-622.
[44] ANTER HM, HASHIM IA, AWADIN W, et al. Novel chitosan oligosaccharide -based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”. Int J Nanomed. 2019;14:4911-4929.
[45] MARTÍNEZ-PÉREZ B, QUINTANAR-GUERRERO D, TAPIA-TAPIA M, et al. Controlled-release biodegradable nanoparticles: From preparation to vaginal applications. Eur J Pharm Sci. 2018;115:185-195.
[46] SUN M, YU X, WANG T, et al. Nasal adaptive chitosan-based nano-vehicles for anti-allergic drug delivery. Int J Bio Macromol. 2019; 135: 1182-1192.
[47] LEI X, YA-TONG F, TIAN-JIAO Z, et al. Chemical modification of chitosan for efficient vaccine delivery. Molecules. 2018;23(2):229.
[48] SINANI G, SESSEVMEZ M, KORAY G, et al. Modified chitosan-based nano adjuvants enhance immunogenicity of protein antigens after mucosal vaccination. Int J Pharmaceut. 2019;569:118592.
[49] LAI JY, LUO LJ. Chitosan-g-poly(N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine administration. Eur J Pharm Biopharm. 2017;113:140-148.
[50] BOLES LR, BUMGARDNER JD, FUJIWARA T, et al. Characterization of trimethyl chitosan/polyethylene glycol derivatized chitosan blend as an injectable and degradable antimicrobial delivery system. Int J Biol Macromol. 2019;133:372-381.
[51] CAPRIFICO AE, FOOT PJS, POLYCARPOU E, et al. Overcoming the blood-brain barrier: functionalised chitosan nanocarriers. Pharmaceutics. 2020;12(11):1013.
[52] CORTÉS H, ALCALÁ-ALCALÁ S, CABALLERO-FLORÁN IH, et al. A reevaluation of chitosan-decorated nanoparticles to cross the blood-brain barrier. Membranes(Basel). 2020;10(9):212.
[53] YAN T, ZHU S, HUI W, et al. Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA. Carbohydr Polym. 2020;250:116781.
[54] WU D, ZHU L, LI Y, et al. Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecan. Int J Pharm. 2020; 584:119394.
|